Editorial Board

doi : 10.1016/S0167-8140(22)04155-X

Volume 172, July 2022, Page ii

Buy The Package and View The Article Online

Contents

doi : 10.1016/S0167-8140(22)04156-1

Buy The Package and View The Article Online

Exposure of the heart in lung cancer radiation therapy: A systematic review of heart doses published during 2013 to 2020

MaeveKearneya1MaeveKeysbc1CorinneFaivre-FinncZheWangdMarianne CAznarde1FrancesDuanebfg1

doi : 10.1016/j.radonc.2022.05.007

Buy The Package and View The Article Online

Multi-institutional phase II study on the safety and efficacy of dynamic tumor tracking-stereotactic body radiotherapy for lung tumors

YukinoriMatsuoaMasahiroHiraokabKatsuyukiKarasawac1MasakiKokubodTakashiSakamotoeNobutakaMukumotoaMitsuhiroNakamurafSatoshiMoritagTakashiMizowakia

doi : 10.1016/j.radonc.2022.04.028

Buy The Package and View The Article Online

The association of internal mammary and medial supraclavicular lymph node radiation technique with clinical outcomes: Results from the EORTC 22922/10925 randomised trial

OritKaidar-PersonabcCatherineFortpieddSandraHoleCarolineWeltensfCarineKirkovegVolkerBudachhKarinePeignaux-CasasnovasiFemkevan der LeijjErnestVonkkMariacarlaVallilNicolaWeidnermMatthiasGuckenbergernEvelineKoiteroAlainFourquetpHarryBartelinkqHenkStruikmansrPhilipPoortmansstfor the EORTC Radiation Oncology and Breast Cancer Groups

doi : 10.1016/j.radonc.2022.05.006

Buy The Package and View The Article Online

Comprehensive summary and retrospective evaluation of prognostic scores for patients with newly diagnosed brain metastases treated with upfront radiosurgery in a modern patient collective

JohannesKraftab1Janita E.van Timmerena1SimonFreiaMichaelMayingeraKimBorskyaCorinnaKirchneraLuisa SabrinaStarkaStephanieTanadini-LangaFabianWolpertcMichaelWellercHenry C.WoodruffdMatthiasGuckenbergeraNicolausAndratschkea

doi : 10.1016/j.radonc.2022.04.024

Buy The Package and View The Article Online

Radiation-induced contrast enhancement following proton radiotherapy for low-grade glioma depends on tumor characteristics and is rarer in children than adults

TanjaEichkornabceJuliaBauerabeEmanuelBahndJonathan W.LischalkgEvaMeixnerabceElisabettaSandriniabceSebastianRegneryabceThomasHeldabceJulianeHörner-RieberabcdeMarkusAlberdKlausHerfarthabceJürgenDebusabcdefLailaKönigabce1SemiHarrabiabce1

doi : 10.1016/j.radonc.2022.05.005

Buy The Package and View The Article Online

Level Ib CTV delineation in nasopharyngeal carcinoma based on lymph node distribution and topographic anatomy

YueZhaoaXiongfeiLiaoaYilingWangaWanyingLanbJingRencNingjingYangcChurongLiaJingyiLangaShichuanZhanga

doi : 10.1016/j.radonc.2022.04.026

Buy The Package and View The Article Online

Prospective assessment of sparing the parotid ducts via MRI sialography for reducing patient reported xerostomia

David V.FriedaTongZhuaShiva K.DasaColetteShenaLawrence B.MarksaXianmingTanbBhishamjit S.Cheraa

doi : 10.1016/j.radonc.2022.05.001

Buy The Package and View The Article Online

Is postoperative radiotherapy an essential treatment for nonmetastatic lymphoepithelial carcinoma of the salivary gland?

XiaoshuangNiuabcPeiyaoLiuabcXinZhouabcXiaoshenWangdChaosuHuabc

doi : 10.1016/j.radonc.2022.05.008

Buy The Package and View The Article Online

Lymph node ratio-dependent prognosis stratification and postoperative radiotherapy utilization in T1-2N1 oral cavity carcinoma

JingboWangaYangLiuaGulidannaShayanaYuchaoMaaJunlinYiab

doi : 10.1016/j.radonc.2022.05.009

Buy The Package and View The Article Online

Sparing submandibular gland to alleviating acute xerostomia in patients with nasopharyngeal carcinoma treated with helical tomotherapy: Evaluation by diffusion kurtosis imaging

Da-weiZhaoabc1Wen-junFanade1Xue-meiFangaf1Yan-rongLuoaJianWeigNan-xiangChengXin-xinZhanggGangLiuhJin-fengLihXiaoZanghMengLihLinglingMengaLinMaa

doi : 10.1016/j.radonc.2022.05.011

Buy The Package and View The Article Online

Similar long-term swallowing outcomes for accelerated, mildly-hypofractionated radiotherapy compared to conventional fractionation in oropharyngeal cancer: A multi-centre study

James M.PriceabCatharine M.WestbLynne M.DixoncZsuzsannaIyizoba-EbozuedKateGarcezaLip WaiLeeaAndrewMcPartlinaFinSlevindAndrewSykesaRobin J.D.PrestwichdDavid J.Thomsonab

doi : 10.1016/j.radonc.2022.05.013

Buy The Package and View The Article Online

Twice-daily thoracic radiotherapy by intensity-modulated radiation therapy (IMRT) compared with simultaneous integrated boost IMRT (SIB-IMRT) with concurrent chemotherapy for patients with limited-stage small cell lung cancer. A propensity-score matched analysis

HongfuSunab1ChengxinLiuab1JingZhangaGuanghuiYangaDanHanabTingtingLiubWeiHuangabBaoshengLiab

doi : 10.1016/j.radonc.2022.01.022

Buy The Package and View The Article Online

Lifetime attributable risk of radiation induced second primary cancer from scattering and scanning proton therapy – A model for out-of-field organs of paediatric patients with cranial cancer

MikaelaDell'OroabMichalaShortaPuthenparampilWilsonbcDylanPeukertdChia-HoHuaeThomas E.MerchanteEvaBezakaf

doi : 10.1016/j.radonc.2022.04.027

Buy The Package and View The Article Online

Oligorecurrent nodal prostate cancer: Radiotherapy quality assurance of the randomized PEACE V-STORM phase II trial

VéraneAchardaMaudJaccardaFrederikVanhouttebShankarSivacReinoHeikkilädPietDirixefNickLiefhooghegFrançois-XavierOttehAlfonsoGomez-IturriagaiCharlienBerghenjMohamedShelankAntonioConde-MorenolFernandoLópez CamposmAlexandrosPapachristofilounMatthiasGuckenbergeroSabineMeersschoutpPaul MartinPutoraqDanielZwahlenr…ThomasZillia

doi : 10.1016/j.radonc.2022.04.020

Buy The Package and View The Article Online

Treatment planning comparison in the PROTECT-trial randomising proton versus photon beam therapy in oesophageal cancer: Results from eight European centres

LoneHoffmannabHannaMortensencMuhammadShamshadabcMaaikeBerbeedNicolaBizzocchieRebeccaBütoffgRichardCantersdGillesDefraeneiMai LykkegaardEhmsencFrancescaFiorinihKarinHaustermansijRyanHulleymErik W.KorevaarlMatthewClarkemSebastianMakockifgChristina T.MuijslLukeMurrayhOwenNicholask…Ditte SlothMøllerab

doi : 10.1016/j.radonc.2022.04.029

Buy The Package and View The Article Online

Causal relation between heart irradiation and survival of lung cancer patients after radiotherapy

CarstenBrinkabUffeBernchouabAndersBertelsenbOlfredHansenacTineSchytteacJacob v.B.HjelmborgdLoisHollowayefMarcelvan HerkgCorinneJohnson-HarthGareth J.PriceghMarianne C.AznargAlanMcWilliamgCorinneFaivre-FinnghChristian R.Hansenab

doi : 10.1016/j.radonc.2022.05.002

Buy The Package and View The Article Online

Clinical use and future requirements of relative biological effectiveness: Survey among all European proton therapy centres

LenaHeuchelaChristianHahnabcJörgPawelkebdBrita SingersSørensenefManjitDosanjhghArminLühra

doi : 10.1016/j.radonc.2022.05.015

Buy The Package and View The Article Online

Further comments on the tubarial glands

WeiLia1Jian-WeiWangc1XuanFangcYanGaobWei-GuangZhangcGuang-YanYua

doi : 10.1016/j.radonc.2022.05.010

Buy The Package and View The Article Online

Evaluating sarcopenia in cancer patients: The role of muscle strength

ZumrutBahata1GulistanBahatb

doi : 10.1016/j.radonc.2021.12.020

Buy The Package and View The Article Online

Letter to the Editor of Radiotherapy and Oncology regarding the paper entitled “50 years of radiotherapy research: Evolution, trends and lessons for the future� by Berger et al. (December 2021, Volume 165)

CarmeloTuscanoaSaidAl SayyadaGiuseppeScenib

doi : 10.1016/j.radonc.2022.04.002

Buy The Package and View The Article Online

Response to Letter to the Editor of Radiotherapy and Oncology regarding the paper entitled “50 years of radiotherapy research: Evolution, trends and lessons for the future“ by Berger et al. (December 2021, volume 165)

ThomasBergeraDavid J.NoblebLeila E.A.ShelleyaKirsten I.HopkinscDuncan B.McLarenbNeil G.BurnetdWilliam H.Nailonae

doi : 10.1016/j.radonc.2022.04.001

Buy The Package and View The Article Online